
Loading, please wait...

Loading, please wait...

Healthcare providers rely heavily on POC glucose meter accuracy to guide critical bedside decisions. However, a recent study involving large inpatient cohorts from Australia and the United States suggests that real-world performance often diverges from manufacturer claims. Researchers analyzed retrospective data to compare point-of-care (POC) devices against laboratory and blood gas methods. The results indicate that systematic biases exist within routine hospital settings, particularly during extremes of glycaemia.
The study found that POC meters frequently exhibit a predictable pattern of error. Specifically, these devices showed a positive bias at lower glucose levels and a negative bias at higher concentrations. While most results remained within clinically "safe" zones on standard error grids, they often failed to meet strict ISO or FDA numerical targets. Consequently, clinicians should interpret POC results with caution when they fall outside normal ranges. Furthermore, blood gas measurements proved to be a much more reliable practical comparator to laboratory gold standards than handheld meters.
One of the most significant findings involves the influence of physiological variables. The research highlighted that low haemoglobin levels significantly amplify negative bias at higher glucose stages. Because anaemia is prevalent among hospitalised patients, this discovery has direct implications for inpatient management. In addition, variations in partial pressure of oxygen (pO2) did not show a consistent impact on meter performance. Therefore, clinicians must consider a patient's haematocrit level when evaluating suspicious glucose readings.
To improve patient safety, hospitals should implement local validation protocols for their glucose monitoring systems. If a POC result seems inconsistent with a patient's clinical presentation, the staff must perform confirmatory laboratory testing. Moreover, narrowing the time window between POC and lab measurements can help identify these discrepancies more effectively. By recognizing the limitations of bedside technology, medical teams can better avoid potential dosing errors and improve overall glycaemic control.
Low haemoglobin or haematocrit levels can cause a negative bias in many POC glucose meters, especially at high blood sugar levels. This means the meter might show a lower result than the actual laboratory glucose concentration.
Yes, the study indicated that blood gas measurements closely parallel laboratory gold standards. Therefore, they serve as a more reliable practical alternative for monitoring critically ill patients compared to standard handheld POC meters.
You should always verify suspicious or extreme POC results with a formal laboratory glucose test. This step is crucial for ensuring accurate diagnosis and preventing inappropriate insulin or glucose administration.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Cooper JAL et al. Real-world performance of point-of-care metre, blood gas and laboratory glucose methods in Australian and American hospital inpatient cohorts. Diabet Med. 2026 Jun 17. doi: 10.1111/dme.70395. PMID: 42310492.
Mishra K et al. Accuracy of point-of-care capillary blood sugar measurements in critically ill patients: An observational study. Int J Crit Illn Inj Sci. 2024 Apr-Jun;14(2):74-78.
Tang Z et al. Validation of Point-of-Care Blood Glucose Monitoring Systems in Hospital Settings. Association for Diagnostics & Laboratory Medicine (ADLM). 2022.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A large-scale retrospective study reveals systematic biases in POC glucose meters compared to laboratory methods. Findings show that anaemia significantly amplifies negative bias at high glucose levels, suggesting a need for confirmatory testing in high-risk inpatient scenarios.
last month

Researchers at Kyushu University have uncovered a novel compound, lipoic acid trisulfide (LASSS), that enhances hepatocyte growth factor (HGF) signaling and protects against nitration-induced protein dysfunction, presenting a potential breakthrough for age-related muscle atrophy and sarcopenia.
Yesterday

A study identifies a critical hypospadias gene-environment interaction. Research shows that the risk gene DNAH8 and DEHP exposure combine to disrupt steroidogenesis and mesenchymal progenitor cell differentiation, significantly increasing the risk of severe urethral malformations in male fetuses.
5 days back

A pre-clinical study reveals that elevated serum pro-N-cadherin levels correlate strongly with severe cardiac fibrosis and diastolic dysfunction following radiation exposure, promising a potential early biomarker for radiation-related heart disease.
3 days back

Discover how biophysical forces shape tissue formation and regeneration. This review explores mechanotransduction in tissue development, from molecular sensors like integrins to tissue-scale flows, highlighting critical implications for regenerative medicine and functional organoid engineering.
Last week

A groundbreaking study utilizes single-cell RNA sequencing to map the tumor microenvironment of ovarian steroid cell tumors-not otherwise specified (SCT-NOS), identifying key steroidogenic subtypes and immune cell distributions that drive hyperandrogenism and tumor progression.
Last week